Culverwell Anthony James
SEC CIK 1693548 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| QNRX | Quoin Pharmaceuticals Ltd. | Dir | 40.4K | $75.0K | — | 3 | 2024-12-23 | 2026-08-31 |
Most active insiders at QNRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LANGER DENNIS | Dir | $128.6K | — |
| 2 | Myers Michael | CEO, Dir | $100.0K | — |
| 3 | Carter Denise P. | COO, Dir | $100.0K | — |
| 4 | Lawlor Sally Bridget | CFO | $50.0K | — |
| 5 | Culverwell Anthony James | Dir | $30.0K | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-01 21:38 | 2026-08-31 | QNRX | Quoin Pharmaceuticals Ltd. | Culverwell Anthony James | Dir | P - Purchase | $4.88 | +6,146 | 40.4K | +18% | +$30.0K |
| 2026-08-28 18:39 | 2026-08-27 | QNRX | Quoin Pharmaceuticals Ltd. | Culverwell Anthony James | Dir | A - Grant | $5.15 | +31.4K | 34.2K | +1,094% | +$161.5K | |
| D | 2024-12-27 | 2024-12-23 | QNRX | Quoin Pharmaceuticals Ltd. | Culverwell Anthony James | Dir | P - Purchase | $0.45 | +100.0K | 100.3K | +31,546% | +$45.0K |
Purchase Sale Sale after option exercise All abbreviations